English
繁體中文
简体中文
日本語
MaxWell Monthly Must-Reads (February 2023)
Welcome to our first MaxWell Monthly Must-Reads blog of 2023! After 2022 – a year full of great scientific advances and discoveries – this month we would like to focus on induced Pluripotent Stem Cells (iPSC) as a great tool for Disease Cell Modelling and for developing novel disease therapies. Development and advancement of patient derived iPSC technology has opened several avenues for scientists to generate relevant and reproducible human in vitro models. iPSC technology has also allowed researchers to…
AxonTracking Competition Winner
AxonTracking Competition Winner After a successful competition we are delighted to announce our AxonTracking Competition winner! Congratulations to our winner, Dr. Maria Sundberg from Sahin lab at Boston Children’s Hospital. Check out Maria’s entries below. How cool do they look! Dr. Maria Sundberg and Dr. Marie Obien (CCO) at our SfN Satellite Event, November 2022 Do you want to try our AxonTracking Assay? Contact us through info@mxwbio.com or schedule a call below with one of our Application Scientists.
AxonTracking Assay Competition
Track your Axon to WIN! The Deadline for entries has been extended to Wednesday 12th October. Do you have a cool image of a tracked neuron using our AxonTracking Assay? Share your image and you could win a $2000 Travel Grant to SfN 2022 in San Diego this November! How to Participate: Send an email to info@mxwbio.com with the subject: AxonTracking Assay Competition Attach the image or link and share a short description of the experiment (max. 100 words) Good…
MaxWell Biosystems Around the World
Travel Blog | Summer 2022 We caught up with some of our MaxWellers that have been busy representing MaxWell Biosystems around the world at lots of conferences such as ISSCR, FENS, CAN and lots more in between. After some rest we wanted to know all about their life while traveling and any hints and tips they might have to share. Here is what they had to say! That’s all for now! Let us know if you enjoyed…
MaxWell Monthly Must-Reads (February 2022)
Welcome to our MaxWell Monthly Must-Reads blog for February 2022. After last months edition about retinal organoids we have arrived at the second blog. We have picked another theme this month and selected five papers that we have read including publications using our MaxOne and MaxTwo system. In February, we have decided to focus on ALS research. The deliberating neurodegenerative disease that forced the “The Iron Horse” (-Lou Gehrig, one of the most decorated baseball legends) to retire is medically known…
MaxWell Monthly Must-Reads (January 2022)
Welcome to our MaxWell Monthly Must-Reads blog for 2022. A new year also means new publications to highlight and new topics to discover. This year as well, for our monthly must-reads, we will choose a theme per month and select five papers that we think are worth reading. Last year we covered a range of topics and in our first edition of 2022, we have decided to focus on Retinal Organoids. Human brain organoids assemble functionally integrated bilateral optic vesicles.…
Join the Conversation with Prof. Kenneth S. Kosik and Dr. Tal Sharf
Interview and Featured Publication Join the Conversation with Prof. Kenneth Kosik and Dr. Tal Sharf Recently, Dr. Tal Sharf, Prof. Kenneth S. Kosik and colleagues released a pre-print on their novel work entitled, “Human brain organoid networks”, currently under revision. Aiming to explore the physiological behavior of neuronal circuits within organoids, this work demonstrates that human brain organoids have self-organized neuronal assemblies of sufficient size, cellular orientation, and functional connectivity to co-activate and generate field potentials from their collective transmembrane…
HyVIS project
MaxWell Biosystems Becomes a Key Partner in a €3M EU-Financed Project “HyVIS”: Next Generation Prosthesis for Visual Restoration Hybrid Synapse for Vision (HyVIS) is a project funded by European Union Horizon 2020 FET-OPEN program 1, which aims to combine several technologies to achieve the groundbreaking restoration of synaptic light-mediated input in retinas with impaired photoreceptors, leading to treatments for diseases such as in retinitis pigmentosa and age-related macular degeneration (AMD). The key focus of HyVIS project is the development of an artificial light-sensitive prosthesis,…
MaxWell Monthly Must-Reads (September 2021)
It is time for a new edition of our monthly blog. In the August edition during the summer holidays, we highlighted the latest developments on CMOS-based MEA technology. For the September edition, we decided to focus on high-throughput screening. With these articles, we would like to prepare you for our upcoming webinar which will be a live demo of our multiwell MEA system, MaxTwo. You can still register for this live demonstration here. In this Monthly Must-Reads edition, we highlighted…
MaxWell Monthly Must-Reads (August 2021)
It is time for a new edition of our monthly blog. In the August edition during the summer holidays, we highlight the latest developments on CMOS-based MEA technology. CMOS-based MEAs are used for detailed investigations of neuronal electrical activity at network and single-cell levels and to evaluate the effect of drugs on neuronal physiological activity. Therefore, for this Monthly Must-Reads edition, we decided to highlight the article written by Yuan X et al., in which switch-matrix (SM) and active-pixel-sensors…